Cancer Research The Future of Cancer Research: Science and Patient Impact  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 48, 5922-5926, November 1, 1988]
© 1988 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Trial, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trial, J.

Cooperation between Early Acting Delayed-type Hypersensitivity T-Cells and Cultured Effector Cells in Tumor Rejection1

JoAnn Trial2

Department of Immunology, The University of Texas M. D. Anderson Hospital and Tumor Institute at Houston, Houston, Texas 77030

Delayed-type hypersensitivity (DTH) to allogeneic tumor cells exhibits two phases, an early reaction peaking at 2 h, and a late phase at 24 h after challenge with viable tumor cells. The purpose of this study was to determine whether DTH to syngeneic tumors also displays two phases and whether either reactivity is involved in tumor rejection in vivo. When normal animals were immunized and challenged with syngeneic regressor tumors induced by UV radiation, a tumor-specific DTH exhibiting both early and late phases was seen. The cells mediating both reactivities were Thy-1+ and L3T4+, but the early DTH cells manifested their reactivity sooner after immunization than the late DTH cells. Adult-thymectomized, X-irradiated mice did not show any greater ability to reject tumors after immune-system reconstitution with either immune population than after reconstitution with normal cells. However, small numbers of the early acting DTH cells acted synergistically with small numbers of cultured T-cells, the latter capable of in vitro cytolysis, to prevent tumor growth. This indicates that the early phase of DTH may be a valuable tool for the potentiation of immunotherapy using cultured cells.

1 This work was supported by Grant RR5511-23 from NIH.

2 To whom requests for reprints should be addressed, at Department of Immunology, P.O. Box 178, U. T. M. D. Anderson Hospital, 1515 Holcombe Boulevard, Houston, TX 77030.

Received 2/26/88. Revised 7/26/88. Accepted 8/ 3/88.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1988 by the American Association for Cancer Research.